Exercise training significantly reduced symptoms of depression in patients with heart failure (SMD -0.38; 95% CI -0.55 to -0.21).
Meta-Analysis (n=3,447)
Does exercise training reduce symptoms of depression in patients with heart failure?
Exercise training significantly reduces depressive symptoms in patients with heart failure, with consistent benefits seen across various age groups, reduced ejection fraction, and different training modalities.
Effect estimate: SMD -0.38 (95% CI -0.55 to -0.21)
AIMS: The aim of this review is to assess the effects of exercise training on the symptoms of depression in heart failure (HF) patients. METHODS AND RESULTS: Randomized controlled trials of exercise training in patients with HF and symptoms of depression were identified. The depression data were pooled using meta-analysis, and 19 studies were identified, with a total of 3447 patients, of which 16 (3226 patients) provided data for the meta-analysis. Exercise training demonstrated significant reductions in the symptoms of depression standardized mean difference (SMD) -0.38, 95% confidence interval (CI) -0.55 to -0.21, and its antidepressive effect was consistent in a number of HF groups, such as in ages under and over 65 years (SMD -0.14, 95% CI -0.22 to -0.07 vs. SMD -0.44, 95% CI -0.61 to -0.27) and EFs of 26 weeks, SMD -0.12, 95% CI -0.20 to -0.04). The beneficial effects were preserved when blind design trials were considered (SMD -0.14, 95% CI -0.22 to -0.07). CONCLUSION: Exercise training significantly decreased the symptoms of depression in patients with HF. This benefit remained unclear in cases of HF with a normal EF and combined aerobic and strength training. Random controlled trials are needed to verify the benefit of exercise in these populations, and in very old, asymptomatic, and severe HF patients.
Tu et al. (Fri,) conducted a meta-analysis in Heart failure with symptoms of depression (n=3,447). Exercise training was evaluated on Symptoms of depression (SMD -0.38, 95% CI -0.55 to -0.21). Exercise training significantly reduced symptoms of depression in patients with heart failure (SMD -0.38; 95% CI -0.55 to -0.21).